HLN 6-K
Haleon plc (HLN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2025
Commission File Number: 001-41411
Haleon plc
(Translation of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form<br>20-F ☒ | Form<br>40-F ☐ |
|---|
EXHIBIT INDEX
| Exhibit Number | Description |
|---|---|
| 99.1 | 26<br>February 2025 - “Holding(s) in Company” |
99.1
26 February 2025
HALEON PLC
("Haleon" or "the Company")
TR-1: Standard form for notification of major holdings
- Issuer Details
ISIN
| GB00BMX86B70 |
|---|
Issuer Name
| HALEON PLC |
|---|
UK or Non-UK Issuer
| UK |
|---|
- Reason for Notification
| Other |
|---|
Comments
| Conversion of American depositary shares into ordinary<br>shares |
|---|
- Details of person subject to the notification obligation
Name
| Pfizer Inc. |
|---|
City of registered office (if applicable)
| New York |
|---|
Country of registered office (if applicable)
| United States of America |
|---|
- Details of the shareholder
| Name | City<br>of registered office | Country<br>of registered office |
|---|---|---|
| State<br>Street Nominees Limited | London | United<br>Kingdom |
- Date on which the threshold was crossed or reached
| 24-Feb-2025 |
|---|
- Date on which Issuer notified
| 26-Feb-2025 |
|---|
- Total positions of person(s) subject to the notification obligation
| %<br>of voting rights attached to shares (total of 8.A) | %<br>of voting rights through financial instruments (total of 8.B 1 +<br>8.B 2) | Total<br>of both in % (8.A + 8.B) | Total<br>number of voting rights held in issuer | |
|---|---|---|---|---|
| Resulting situation<br>on the date on which threshold was crossed or reached | 7.310000 | 0.000000 | 7.310000 | 661709764 |
| Position of<br>previous notification (if applicable) | 7.310000 | 0.000000 | 7.310000 |
- Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
|---|---|---|---|---|
| Ordinary Shares<br>GB00BMX86B70 | 661709764 | 7.310000 | ||
| Sub<br>Total 8.A | 661709764 | 7.310000% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is<br>exercised/converted | % of voting rights |
|---|---|---|---|---|
| Sub<br>Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
|---|---|---|---|---|---|
| Sub<br>Total 8.B2 |
- Information in relation to the person subject to the notification obligation
| 1. Person subject to the notification obligation is not controlled<br>by any natural person or legal entity and does not control any<br>other undertaking(s) holding directly or indirectly an interest in<br>the (underlying) issuer. | ||||
|---|---|---|---|---|
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable<br>threshold | %<br>of voting rights through financial instruments if it equals or is<br>higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable<br>threshold |
| --- | --- | --- | --- | --- |
- In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
- Additional Information
| This notification relates to the conversion by Pfizer Inc.<br>("Pfizer") of its holding of American depositary shares<br>representing ordinary shares of Haleon plc ("Haleon") into Haleon<br>ordinary shares.<br><br><br>These calculations are based on Haleon's issued voting share<br>capital of 9,054,145,714 ordinary shares with voting rights, as<br>communicated by Haleon in its announcement on total voting rights<br>and capital dated 3 February 2025.<br><br><br>Pfizer holds its Haleon ordinary shares through State Street<br>Nominees Limited, which holds the legal title to those shares on<br>Pfizer's behalf. |
|---|
- Date of Completion
| 26-Feb-2025 |
|---|
- Place Of Completion
| New York, USA |
|---|
Amanda Mellor, Company Secretary
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HALEON PLC<br><br><br>(Registrant) | |||
|---|---|---|---|
| Date: February 26,<br>2025 | By: | /s/<br>Amanda Mellor | |
| Name: | Amanda<br>Mellor | ||
| Title: | Company<br>Secretary |